ETF Managers Group’s Arcturus Therapeutics ARCT Stock Holding History

ETF Managers Group’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$213K	Buy	+8,890	New	+$159K	0.01%	577
2022 Q4	–	Sell	-7,843	Closed	-$116K	–	529
2022 Q3	$116K	Sell	7,843 -504	-6%	-$8.46K	﹤0.01%	643
2022 Q2	$129K	Buy	8,347 +347	+4%	+$6.81K	﹤0.01%	673
2022 Q1	$220K	Buy	8,000 +31	+0.4%	+$791	﹤0.01%	597
2021 Q4	$310K	Sell	7,969 -1,150	-13%	-$46.9K	0.01%	591
2021 Q3	$426K	Buy	9,119 +1,356	+17%	+$60.8K	0.01%	562
2021 Q2	$268K	Sell	7,763 -10,058	-56%	-$340K	﹤0.01%	592
2021 Q1	$691K	Buy	17,821 +5,908	+50%	+$352K	0.01%	334
2020 Q4	$556K	Sell	11,913 -1,755	-13%	-$119K	0.01%	322
2020 Q3	$584K	Buy	13,668 +7,008	+105%	+$348K	0.02%	278
2020 Q2	$313K	Buy	+6,660	New	+$230K	0.01%	392

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

ETF Managers Group's ARCT Position: Q1 2023 in Review

ETF Managers Group opened a new position in Arcturus Therapeutics (ARCT) in Q1 2023: 8,890 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #577 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in ARCT as recently as Q3 2022.

ETF Managers Group first reported a position in ARCT in Q2 2020 and has held it in 11 quarters since. The position peaked at $691K in Q1 2021. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2023.

ETF Managers Group held 8,890 shares of Arcturus Therapeutics worth $213K as of Q1 2023.
Arcturus Therapeutics was a new ETF Managers Group position in Q1 2023.
Arcturus Therapeutics made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #577 holding.
ETF Managers Group first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 11 quarters since.
ETF Managers Group's Arcturus Therapeutics position peaked at $691K in Q1 2021.
124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.